Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
47 active Medicare policies list M81.8, and 17 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Feb 1, 2016
17 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 12 · All Aetna policies
| Policy | Effective | Status of M81.8 |
|---|---|---|
| Acupuncture and Dry Needling | Apr 5, 2023 | Covered |
| Back Pain - Invasive Procedures | Mar 13, 2024 | Covered |
| Biochemical Markers of Bone Remodeling | Jul 27, 2023 | Covered |
| Bone Mass Measurements | Apr 5, 2023 | Covered |
| Calcitriol, Etelcalcetide, and Paricalcitol Injections | Feb 1, 2024 | Covered |
| Genetic Testing | Feb 27, 2024 |
JJ · Effective Sep 18, 2022
JM · Effective Sep 18, 2022
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Apr 1, 2018
JK · Effective Apr 1, 2018
JE · Effective Feb 3, 2017
JF · Effective Feb 3, 2017
JJ · Effective Jan 29, 2023
JM · Effective Jan 29, 2023
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
JL · Effective Oct 1, 2025
J5 · Effective Jan 1, 2026
National · Effective Jan 4, 2024
National · Effective Jan 1, 2025
J6 · Effective Jul 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2026
J9 · Effective Dec 18, 2025
National · Effective Aug 6, 2026
J5 · Effective Oct 1, 2024
National · Effective Aug 14, 2025
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2023
J9 · Effective Oct 1, 2023
| Infrared Therapy | Sep 8, 2023 | Covered |
|---|
| Pulsed Electromagnetic Stimulation | Mar 14, 2023 | Covered |
|---|
| Salivary Tests | Aug 31, 2023 | Covered |
|---|
| Strontium Chloride Sr-89 | Dec 15, 2023 | Covered |
|---|
| Policy | Effective | Status of M81.8 |
|---|---|---|
| Thyroid Testing | Apr 15, 2026 | Covered |
| Vitamin D Testing | Oct 1, 2026 | Covered |
| Policy | Effective | Status of M81.8 |
|---|---|---|
| Denosumab | Oct 1, 2026 | Covered |
| Evenity (Romosozumab-Aqqg) | Dec 1, 2025 | Covered |
| Policy | Effective | Status of M81.8 |
|---|---|---|
| Transvaginal Ultrasound, Non-Obstetrical | Mar 15, 2026 | Not covered |